Author:
Rossi Roberta Elisa,Massironi Sara
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference13 articles.
1. Xu Z, Wang L, Dai S et al. Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States. JAMA Netw. Open 2021;4:e2124750.
2. Concors SJ, Sinnamon AJ, Folkert IW et al. Predictors of Metastases in Rectal Neuroendocrine Tumors: Results of a National Cohort Study. Dis Colon Rectum 2018;61:1372–1379.
3. Chida K, Watanabe J, Hirasawa K et al. A novel risk-scoring system for predicting 18 lymph node metastasis of rectal neuroendocrine tumors. Ann Gastroenterol Surg. 2020;4:562–570.
4. Zheng X, Wu M, Er L et al. Risk factors for lymph node metastasis and prognosis in 2 colorectal neuroendocrine tumours. Int J Colorectal Dis. 2022;37:421–428.
5. Gallo C, Rossi RE, Cavalcoli F et al. Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance. World J Gastroenterol. 2022;28(1123–4):1138.